C hest pain is a common presenting complaint in the emergency department that requires efficient risk stratification, timely initiation of treatment in highrisk patients and safe determination of patient disposition. Several studies have been published that stratify the risk of patients in the emergency department with chest pain. [1][2][3][4][5] However, only the Thrombolysis in Myocardial Infarction (TIMI) risk score, which was initially developed for use in patients with unstable angina or non-ST-segment elevation myocardial infarction or both, 6 has been broadly validated in several independent emergency department populations with chest pain and thus constitutes the highest level of evidence available. The TIMI risk score assigns each of seven predictors a value of one point, allowing stratification of patients into one of eight prognostic categories (Box 1). 6 The clinical end points are acute myocardial infarction, coronary revascularization and death from any cause.A robust estimate of the performance of the TIMI risk score obtained from a systematic review may prove useful to both clinicians and researchers. Clinicians would have a reliable quantitative estimate of a patient's short-term risk of a cardiac event. This could be used as an adjunct to clinical acumen and as a tool to communicate risk to patients in a shared decision-making model of care.7 Researchers would also have an estimate of the prognostic accuracy of the TIMI risk score derived from different practice settings and patient populations that represent a wide variety of ethnic backgrounds. This estimate may serve as a useful baseline for comparison as emerging clinical prediction rules and imaging modalities continue to refine our approach to diagnosis and risk stratification in patients in the emergency department with potential acute coronary syndromes.We conducted a comprehensive systematic review and meta-analysis to assess the methodological quality and prognostic performance of studies that had prospectively validated the TIMI risk score in patients in the emergency department.
MethodsThis systematic review and meta-analysis adheres to the reporting guidelines of Meta-analysis of Observational Studies in Epidemiology (MOOSE) 8 and the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) statement as applicable to meta-analyses of observational studies. Background: The Thrombolysis in Myocardial Infarction (TIMI) risk score uses clinical data to predict the short-term risk of acute myocardial infarction, coronary revascularization or death from any cause. It was originally developed for use in patients with unstable angina or non-STelevation myocardial infarction. We sought to expand the clinical application of the TIMI risk score by assessing its prognostic accuracy in patients in the emergency department with potential acute coronary syndromes.